CN Patent
CN100569307C — 用于注射液态药物的手持式电控注射装置
Assigned to Ares Trading SA · Expires 2009-12-16 · 16y expired
What this patent protects
本申请中描述了一种用于注射预定剂量的液态药物的手持式电控注射装置(1),其具有容纳药筒(4)的壳体(2),所述药筒(4)内含有液态药物,并且具有一个用于接触患者皮肤的接触面(16);以及致动器装置(41),其用于在壳体(2)内将药筒(4)移动至接触面(16)或从接触面(16)处移开。
USPTO Abstract
本申请中描述了一种用于注射预定剂量的液态药物的手持式电控注射装置(1),其具有容纳药筒(4)的壳体(2),所述药筒(4)内含有液态药物,并且具有一个用于接触患者皮肤的接触面(16);以及致动器装置(41),其用于在壳体(2)内将药筒(4)移动至接触面(16)或从接触面(16)处移开。
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.